Recent reports of retinal atrophy have raised concerns on potential long-term safety.
At the ESCRS meeting, Sir Harold Ridley’s legacy was put on display in a pop-up museum installation
A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
Novel treatment results in macular hole closure.
Code-free deep learning models are expected to find applications across a range of areas to improve patient care, increase accessibility to healthcare, accelerate clinical research and enhance medical education.
Surgeons can consider a relatively simple, inexpensive, efficient and accessible incision-free procedure to preserve blebs.
Recent improvements in electroretinography are making the technique more accessible for general use. It has a wide range of clinical applications.
Laser vision advancements have made safe, reliable and stable procedures a reality.
A look at what’s in the therapeutic delivery pipeline for these disorders.
Diabetic Retinopathy ranked as the fifth most common cause of blindness among adults aged 50 and older in 2020 according to data from the Global Burden of Disease study. Aude Couturier, MD shares her experience of using advanced imaging technologies to optimize diagnosis and surgical management of her DR patients in our latest Case of the Month.
Multimodal imaging and a systemic work-up failed to identify any underlying disorder for the hemorrhages
Code-free deep learning models are expected to find applications across a range of areas to improve patient care, increase accessibility to healthcare, accelerate clinical research and enhance medical education.
Methods using a combination of non-invasive thermal treatments and meibomian gland expression seem to be particularly effective.
A new monofocal IOL was found to provide stability in the capsular bag 1 week and 1 month after implantation, with good refractive outcomes.
Identifying all genetic culprits may improve diagnostics and prognoses
Results of a study analysing cytokine levels in the aqueous humour and serum of patients with nonproliferative diabetic retinopathy with and without diabetic macular oedema support further research investigating transforming growth factor-β-induced Gene Human Clone 30 (BIGH3) as a potential biomarker for DMO.
More testing is needed to ensure accuracy across different groups
Panelists discuss how longer-acting treatments will enable extended intervals between visits while requiring careful adjustment of monitoring protocols and clinic workflows to balance reduced treatment burden with maintaining adequate disease surveillance.
Investigators emphasised a significant unmet need for home-based monitoring of visual function with patient-centric technologies
Patients underwent electropuncture, low-intensity laser stimulation of the ciliary muscle, combined therapy and optical-reflex treatment of accommodation
This article is produced by Roche for healthcare professionals and is not intended to provide medical advice and/or treatment guidance. This website is not country-specific and therefore may contain information which is not applicable to your country.
To maintain treatment quality and patient and staff safety in the SARS-CoV-2 era, it is important to minimise clinic visits and maximise use of imaging modalities. In addition, extending treatment intervals with longer-acting agents is key to maximising safety and patients’ vision outcomes.
Correcting abnormal tear film osmolarity before cataract surgery enables more accurate measurements to be captured, reducing residual refractive error.
A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
How studies into myopia management can increase access to vision care
Simply slowing disease progression is no longer enough